-308G>A

Association between TNF-α-308G>A and -238G>A gene polymorphisms and TNF-α serum levels in Mexican colorectal cancer patients

I. A. Gutiérrez-Hurtado, Puebla-Pérez, A. M., Delgado-Saucedo, J. I., Figuera, L. E., Zúñiga-González, G. M., Gomez-Mariscal, K., Ronquillo-Carreón, C. A., Gallegos-Arreola, M. P., Gutiérrez-Hurtado, I. A., Puebla-Pérez, A. M., Delgado-Saucedo, J. I., Figuera, L. E., Zúñiga-González, G. M., Gomez-Mariscal, K., Ronquillo-Carreón, C. A., and Gallegos-Arreola, M. P., Association between TNF-α-308G>A and -238G>A gene polymorphisms and TNF-α serum levels in Mexican colorectal cancer patients, vol. 15, p. -, 2016.

The objective of this study was to examine the association between TNF-α serum levels and -308G>A and -238G>A polymorphisms in the corresponding gene by comparing healthy subjects to colorectal cancer (CRC) patients from a Mexican population. Serum levels of TNF-α were found to significantly differ between CRC patients and controls (P = 0.001), but no relationship between the -308G>A and -238G>A polymorphisms and increased CRC risk was established (P > 0.05).

Association of the tumor necrosis factor-alpha -308G>A polymorphism with breast cancer in Mexican women

G. L. Flores-Ramos, A. De Dios, E. -, Puebla-Pérez, A. M., Figuera-Villanueva, L. E., Ramos-Silva, A., Ramírez-Patiño, R., Delgado-Saucedo, J. I., Salas-González, E., Zúñiga-González, G. M., Alonzo-Rojo, A., Gutiérrez-Hurtado, I., and Gallegos-Arreola, M. P., Association of the tumor necrosis factor-alpha -308G>A polymorphism with breast cancer in Mexican women, vol. 12, pp. 5680-5693, 2013.

The tumor necrosis factor-alpha (TNF-α) gene plays an important role in cell proliferation, differentiation, apoptosis, lipid metabolism, coagulation, insulin resistance, and endothelial function. Polymorphisms of TNF-α have been associated with cancer. We examined the role of the -308G>A polymorphism in this gene by comparing the genotypes of 294 healthy Mexican women with those of 465 Mexican women with breast cancer. The observed genotype frequencies for controls and breast cancer patients were 1 and 14% for AA, 13 and 21% for GA, and 86 and 65% for GG, respectively.

Subscribe to -308G>A